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Hypothalamus–pituitary–adrenal axisCarnitine-deﬁcient juvenile visceral steatosis (JVS) mice, suffering from fatty acid metabolism abnormalities,
have reduced locomotor activity after fasting. We examined whether JVS mice exhibit speciﬁc defect in the
feeding response to fasting, a key process of anti-famine homeostatic mechanism. Carnitine-deﬁcient JVS
mice showed grossly defective feeding response to 24 h-fasting, with almost no food intake in the ﬁrst 4 h, in
marked contrast to control animals. JVS mice also showed defective acyl-ghrelin response to fasting, less
suppressed leptin, and seemingly normal corticotropin-releasing factor (CRF) expression in the hypotha-
lamus despite markedly increased plasma corticosterone. The anorectic response was ameliorated by
intraperitoneal administration of carnitine or acyl-ghrelin, with decreased CRF expression. Intracerebroven-
tricular treatment of CRF type 2 receptor antagonist, anti-sauvagine-30, recovered the defective feeding
response of 24 h-fasted JVS mice. The defective feeding response to fasting in carnitine-deﬁcient JVS mice is
due to the defective acyl-ghrelin and enhanced CRF signaling in the hypothalamus through fatty acid
metabolism abnormalities. In this animal model, carnitine normalizes the feeding response through an
inhibition of CRF.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Juvenile visceral steatosis (JVS) mice, an animal model of systemic
carnitine deﬁciencywith genetically defected organic cation transport-
er 2 (OCTN2), suffer from fatty liver, hypoglycemia, hyperammonemia,
growth retardation, and cardiac hypertrophy [1-6]. The abnormalities
could be caused by accumulation of long-chain fatty acids, which are
not well metabolized due to the disturbed entry into mitochondria in
carnitine-deﬁcient state [1-4,7]. As a proof, the abnormalities are; ACTH, adrenocorticotropic
- and amphetamine-regulated
y acid oxidation; icv, intracer-




ll rights reserved.ameliorated by intraperitoneal administration of carnitine. Fatty liver
and locomotor activity reduction observed in this animal model are
deteriorated under fasting condition [8-10] since fatty acids are amajor
energy source in fasting [10]. Fasting is avoided in the treatment of
patients with fatty acid oxidation (FAO) disorders [11,12] in order to
prevent accelerated fatty acid metabolism and hypoglycemia.
We have previously reported reduced locomotor activity after
fasting in JVS mice, with an involvement of orexin neuronal activity in
the hypothalamus [9]. Orexin/hypocretin neuropeptides are produced
by a small set of neurons in the lateral hypothalamic and perifornical
areas, which are involved in the control of feeding behavior, wake-
fulness,motor activity, andmetabolic and autonomic functions. In fact,
orexinwas considered to be responsible for the anorexia of JVSmice in
the weaning period [13] although the hypothesis needs to be further
examined.
A compelling evidence supports the existence of a homeostatic
system that dynamically adjusts energy intake and expenditure to
Fig. 1. (A) Food intake of wild type (open column, n= 16) and JVS (closed column,
n=13) mice under free-feeding condition was measured in light and dark phases
(light, 0700–1900 h; dark, 1900–0700 h; total, 0700–0700 h at the next day). Results
are expressed as mean±SD. ⁎, pb0.05 vs. wild type mice of the respective phases by
Student t test. (B) Food intake of fed or 24 h-fasted wild type (open column, fed:
n= 16, fasted: n= 16) and JVS (closed column, fed: n= 13, fasted: n= 14) mice was
measured (1 h, 0700–0800 h; 2 h, 0700–0900 h; 4 h, 0700–1100 h; 12 h, 0700–1900 h;
24 h, 0700–0700 h at the next day). Results are expressed as mean±SD. ⁎, pb0.05 vs.
wild type mice of the same feeding condition by Student t test. #, pb0.05 vs. fed
condition of the respective genotypes by Student t test.
1088 T. Sakoguchi et al. / Biochimica et Biophysica Acta 1792 (2009) 1087–1093keep body fat mass within a very narrow range [14,15]. The feeding
response to fasting and starvation is essential for the survival of all
animals and humans and it is thought that energy homeostasis
operates primarily to defend against weight loss rather than weight
gain over the course of evolution. Through the detailed analysis on
feeding behavior of JVS mice, we found that the mice do not show
anorexia under free-feeding condition different from during weaning
period [13], but fail to respond to 24 h-fasting in marked contrast
to normal animals. We now report that the defective secretion of
acyl-ghrelin, an appetite-stimulatory gastric hormone [16,17], and
increased activity of anorexigenic corticotrophin-releasing factor
(CRF) in the hypothalamus of the animals underlie the defective
feeding response to fasting and failure of the anti-famine homeostatic
mechanism.
2. Materials and methods
2.1. Animals
Wild and homozygous mutant JVS mice were obtained by cross-
mating the heterozygousmice or bymating homozygousmutantmale
and heterozygous female mice. The mice residing in a closed colony
originated from C3H·OH strain were used for all experiments. The
mice were kept at 22±1.0 °C with free access to water and food
(CE-2; CLEA Japan, Tokyo, Japan) and with lights on 12 h/day (0700–
1900 h). Neonatal (7–28 days of age) JVS mice were treated intra-
peritoneally with L-carnitine·HCl (5 μmol/mouse; Sigma-Aldrich,
St. Louis, MO), dissolved in physiological saline and neutralized
with 0.2 M NaOH, as described previously [2]. For the homozygous
mutant mice, two to three mice were kept in one cage to suppress
the mortality. At 8 weeks of age, the mutant mice were housed
individually. Male mice at 10–16 weeks of age were used for all
experiments.
This study was approved by the Ethical Committee for Animal
Experimentation at Kagoshima University, which was standardized to
Japanese national guidelines for animal experiments.
2.2. Genotyping and operation for intracerebroventricular injection
For genotyping, genomic DNA was extracted with a buffer [50 mM
NaCl, 10 mM Tris–HCl, 2.5 mM MgCl2, 0.45% (v/v) NP40, 0.45% (v/v)
Tween 20, pH 8.4] from part of their ear. The L352R mutation of
Slc22a5 (GenBank: AF111425) in the mutant mice was detected
by ampliﬁcation with primers 5′-AGATGCACTGGCAAAGGTTATA-3′
(intron 5) and 5′-TTCAACAGCCGCCAGTAGGA-3′ (exon 6), followed
by digestion with Cfr13I (Bio-Rad, Hercules, CA) [9].
For intracerebroventricular (icv) administration, the anesthetized
mice were placed in a David Kopf stereotaxic apparatus with a mouse
adapter. The stereotaxic coordinates for lateral cerebroventriclar
injections were 0.9 mm posterior to bregma, 0.9 mm lateral to mid-
line, and 4.2 mm below the dura [18,19]. The mice were allowed to
recover for at least 1 week after this operation.
2.3. Preparation of drugs
For intraperitoneal (ip) administration, L-carnitine·HCl (10 μmol/
mouse) was dissolved in physiological saline and neutralized with
0.2 M NaOH. Acyl-ghrelin (10 nmol/mouse, Yanaihara Institute, Inc.,
Shizuoka, Japan) was dissolved in physiological saline. For icv admi-
nistration, neuropeptide Y (NPY: 3.0 μg/mouse, Yanaihara Institute,
Inc., Shizuoka, Japan) and anti-sauvagine-30 (CRF type 2 receptor
antagonist, 0.75 μg/mouse; Polypeptide Laboratories, Torrance, CA)
were dissolved in artiﬁcial cerebrospinal ﬂuid (aCSF: 138.9 mM NaCl,
3.4 mM KCl, 1.26 mM CaCl2, 4.0 mMNaHCO3, 0.6 mMNaH2PO4·2H2O,
5.6 mM glucose) [18,19]. Carnitine (100 nmol/mouse; Sigma-Aldrich)
was dissolved in physiological saline.2.4. Food intake
The cumulative food intake was examined in mice under free-
feeding and re-feeding after 24 h-fasting. Measurements were started
at 0700 h except as otherwise indicated. Before re-feeding, food was
deprived frommice for 24 h, with free accessing to water. After the ip
administration of vehicle (150 μl of saline), acyl-ghrelin (10 nmol/
150 μl of saline), or carnitine (L-carnitine·HCl neutralized with NaOH,
10 μmol/150 μl) at 0700 h, or the icv administration of 4 μl of vehicle
(saline or aCSF) or indicated chemicals at 0700 h, the cumulative food
intake was calculated for indicated hour. Food intake was determined
by calculating the difference between the weight of supplied standard
chow and the weight of remained chow and visible split at the end of
each time point.
2.5. Measurement of metabolic parameters and hormone concentrations
The body weight wasmeasured at 0700–0900 h. For measurement
of metabolic parameters and hormone concentration except ghrelin,
ACTH, and corticosterone, the mice were anesthetized with sodium
pentobarbital (100mg/kg, ip) and blood samples were collected from
heart using syringe containing EDTA (5 μl of 200 mM) between 0700
and 0900 h. For ghrelin, ACTH, and corticosterone, blood drops were
Table 1
Physiological and biochemical analyses of wild type and JVS mice.
Fed Fasting
Wild JVS Wild JVS
Body weight (g) 24.7±2.6 4.9±2.6 1.3±2.4b 0.6±1.7b
Epididymal fat (mg) 99±99 52±96 09±56b 20±55b
Glucose (mg/dl) 61±16 65±9 30±18b 18±40b
FFA (μEq/l) 10±40 60±110a 45±111b 487±1380a,b
Insulin (ng/ml) 0.57±0.33 0.18±0.98a 0.14±0.17b 0.05±0.04b
Leptin (ng/ml) 3.35±0.77 6.26±3.60 0.32±0.19b 2.67±2.26a
Acyl-ghrelin (fmol/ml) 8±11 40±13 379±309b 25±15a
Desacyl-ghrelin
(fmol/ml)
271±35 1013±292a 1468±427b 1635±984
Desacyl- to acyl-ghrelin 7.7±2.1 22.2±4.1a 5.2±2.4 73.2±26.1a,b
Corticosterone (ng/ml) 1.2±0.3 109±130 140±104b 517±376a,b
ACTH (pg/ml) 16.7±7.8 27.5±16.2 26.1±16.0 2.8±5.5a,b
Results are expressed as mean±SD (n=6). Fed and fasting mean free-feeding and
24 h-food deprivation condition, respectively.
a pb0.05 vs. wild type mice of the same feeding condition by Student t test.
b pb0.05 vs. fed condition of the respective genotypes by Student t test.
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pitation. Plasma was stored at −80 °C until analysis. After the mice
were killed, the hypothalamic block, stomach, and epididymal fatwere
removed, and then frozen in liquid nitrogen. They were stored at
−80 °C until RNA extraction. Plasma glucose and free fatty acids (FFA)Fig. 2. (A) Effect of intraperitoneal administration of saline (Na, 150 μl), carnitine (Cn, 10 μm
fasting in wild type (open column, Na: n= 13, Cn: n= 13, Ghr: n= 4) and JVS (closed colu
0700–1100 h; 12 h, 0700–1900 h; 24 h, 0700–0700 h at the next day). Results are expressed
differences between the treatments in the same genotype at each time point were assessed
are not signiﬁcantly different. (B) Effect of intracerebroventricular administration of aCSF
cumulative food intake (1 h, 0700–0800 h; 2 h, 0700–0900 h) after 24 h-fasting in JVS micwere measured by kits using glucose oxidase and acyl-CoA oxidase,
respectively (Wako, Osaka, Japan). Plasma insulin (Morinaga, Kana-
zawa, Japan), leptin (R&D Systems, Minneapolis, MN), acyl-ghrelin
(Mitsubishi Kagaku, Tokyo, Japan), desacyl-ghrelin (Mitsubishi
Kagaku), corticosterone (Assay Designs, Ann Arbor, MI), and ACTH
(MD Biosciences, St. Paul, MN) were measured by the respective kit
based on enzyme immunoassay.
2.6. Real-time PCR for quantiﬁcation of mRNA
Micewere fed or fasted for 24h. Themicewere killedbydecapitation
or cervical dislocation. Total RNA was isolated from the hypothalamic
block, stomach, and epididymal fat with the method of Chomczynski
and Sacchi [20]. Isolated RNA was treated with DNase treatment to
delete genomic contamination. First-strand cDNA synthesis was per-
formed using 5 μg of total RNA and oligo-(dT)12–18 priming following
the manufacturer's instructions (Invitrogen, Carlsbad, CA). Real-time
quantitative PCR was performed using SYBR-green chemistry on a
TAKARA detection system (TAKARA, Shiga, Japan). Reactions were
performedunder the standard conditions recommended by themanu-
facturer.We used themouse cyclophilin gene as an internal control for
all samples. All expression data were normalized to the level of cyclo-
philin expression from the individual sample. The following primers
were used for real-time PCR: cyclophilin, 5′-GGTGGAGAGCACCAAGAC-
AGA-3′ (forward) and 5′-GCCGGAGTCGACAATGATG-3′ (reverse) [21];ol/150 μl), or acyl-ghrelin (Ghr, 10 nmol/150 μl) on cumulative food intake after 24 h-
mn, Na: n= 11, Cn: n= 9, Ghr: n= 8) mice (1 h, 0700–0800 h; 2 h, 0700–0900 h; 4 h,
as mean±SD. ⁎, pb0.05 vs. wild type mice of the same treatment by Student t test. The
by one-way ANOVA. Values sharing identical superscripts (alphabetical or Greek letter)
(4 μl, n= 4), carnitine (Cn, 100 nmol/4 μl, n= 5), or NPY (10 nmol/4 μl, n= 4) on
e (closed column). #, pb0.05 vs. aCSF injected mice at each time point.
Fig. 3. mRNA levels of leptin in the white adipose tissue (WAT) (A), ghrelin in the
stomach (B), NPY (C), AGRP (D), POMC (E), CART (F), orexin (G), and CRF (H) in the
hypothalamus of wild type (open column) and JVS (closed column) mice were
measured by real-time PCR. The mRNA levels relative to cyclophilin were calculated
with the value of fed wild type mice set at 1.0. The numbers of samples are from 4 to 12.
Results are expressed as mean±SD. ⁎, pb0.05 vs. wild type mice of the same feeding
condition by Student t test. #, pb0.05 vs. fed condition of the respective genotypes by
Student t test.
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TGCCAGAGTCTG-3′ (reverse) [22]; ghrelin, 5′-AGGAGCTGGAGATCAG-
GTTCAAT-3′ (forward) and 5′-CTGCTGATACTGAGCTCCTGACAG-3′
(reverse) [23]; NPY, 5′-CTCCGCTCTGCGACACTAC-3′ (forward) and
5′-AATCAGTGTCTCAGGGCT-3′ (reverse) [21]; AGRP, 5′-GCGGAGGTGC-
TAGATCCA-3′ (forward) and 5′-AGGACTCGTGCAGCCTTA-3′ (reverse)
[21]; POMC, 5′-GGCTTGCAAACTCGACCTCT-3′ (forward) and 5′-TGA-
CCCATGACGTACTTCCG-3′ (reverse) [24]; CART, 5′-GCAGATCGAAG-
CGTTGCAA-3′ (forward) and 5′-TTGGCCGTACTTCTTCTCGTAGA-3′
(reverse) [24]; orexin A, 5′-CGTAACTACCACCGCTTTAGCA-3′ (forward)
and 5′-TGCCATTTACCAAGAGACTGACAG-3′ (reverse) [24]; and CRF,
5′-CCGGGCAGAGCAGTTAGC-3′ (forward) and 5′-CAACATTTCATTTC-
CCGATAATCTC-3′ (reverse) [25].
2.7. Statistical analysis
Results are expressed as the mean±standard deviation (SD).The
signiﬁcance of differences between the groups was evaluated by
un-paired Student t test or one-way analysis of variance (ANOVA)
followed by Tukey–Kramer method for multiple comparison. JMP
software (SAS Institute, Tokyo, Japan) was used for statistical analysis.
3. Results
3.1. Food intake of wild type and JVS mice under free-feeding or
re-feeding condition after 24 h-fasting
Both wild type and JVS mice showed an equivalent food intake in
a day under free-feeding condition (Fig. 1A). However, JVS mice
signiﬁcantly took more food in light phase and less in dark phase than
wild type mice. After 24 h-fasting, wild type mice took more foods in
the ﬁrst 1, 2, 4, 12, and 24 h, as compared with food intake under
free-feeding condition (Fig. 1B). On the other hand, JVS mice failed to
show the feeding response to 24 h-fasting during 4 h-observation
period and showed signiﬁcantly decreased feeding response at 12
and 24 h.
3.2. Metabolic and hormone analysis in wild type and JVS mice
Both wild type and JVS mice had no difference in body weight and
epididymal fat weight under free-feeding condition (Table 1). JVS
mice had signiﬁcantly higher FFA and desacyl-ghrelin and lower
insulin in the blood than in control animals. After 24 h-fasting, they
lost body weight and epididymal fat weight similarly, as reﬂected in
lower glucose and insulin and higher FFA and corticosterone levels
(Table 1). However, JVS mice had markedly increased FFA, leptin, and
corticosterone after fasting than in control animals. The plasma
glucose levels did not differ signiﬁcantly under fasted and fed
conditions in JVS and control mice. It was surprising in JVS mice
that orexigenic acyl-ghrelin did not respond to fasting andmost of the
ghrelin forms in the blood is anorexigenic desacyl-ghrelin [19,24], as
shown in the markedly increased ratio of desacyl-ghrelin to acyl-
ghrelin compared to controls (Table 1).
3.3. Effects of carnitine, acyl-ghrelin, and NPY administration on food
intake in 24 h-fasted wild type and JVS mice
Ip administration of carnitine (10 μmol) or acyl-ghrelin (10 nmol)
normalized the decreased feeding response to 24 h-fasting in
JVS mice, at the doses that did not affect the food intake in wild
type animals (Fig. 2A). In contrast, icv administration of carnitine
(100 nmol) had no effect in 24 h-fasted JVS mice, indicating that
carnitine acts in the periphery (Fig. 2B). Icv administration of carni-
tine (1 μmol) to 24 h-fasted JVS mice showed no signiﬁcant effects
(data not shown). On the other hand, icv administration of orexi-
genic NPY that is situated downstream from ghrelin [26] markedlyincreased food intake in JVS mice under the re-feeding condition
(Fig. 2B).
3.4. mRNA levels of leptin in white adipose tissue (WAT), ghrelin in
stomach, and appetite-regulated peptides in hypothalamus
Leptin expression in the WAT decreased and ghrelin expression
in the stomach increased after fasting in wild type animals (Fig. 3A
and B), in accordance with plasma concentrations of the respective
hormones (Table 1). However, in JVS mice, leptin expression para-
doxically increased after fasting, with no change of ghrelin, which is
Fig. 5. Effect of intracerebroventricular administration of aCSF (4 μl) or CRF type 2
receptor antagonist (CRF2RA, anti-sauvagine-30, 0.75 μg/4 μl of aCSF) on cumulative
food intake (2 h, 0700–0900 h; 4 h, 0700–1100 h) in 24 h-fasted wild type (aCSF, n= 5;
antagonist, n= 3) and JVS (aCSF, n= 7; antagonist, n= 7) mice. ⁎, pb0.05 vs. wild
type mice of the same treatment at each time point by Student t test. #, pb0.05 vs. aCSF
administered mice of the respective genotypes at each time point by Student t test.
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sion of orexigenic NPY/AGRP and decreased anorexigenic POMC
in the hypothalamus (Fig. 3C–H), suggesting the existence of some
adaptive response to fasting in this animal model. Neither CART nor
orexin expression is altered after fasting both in wild type and JVS
mice. However, despite markedly increased corticosterone levels, CRF
expression of JVS mice remained at similar levels to controls in fasting
and free-feeding conditions, suggesting the increased CRF activity in
this animal model.
3.5. Effects of carnitine or acyl-ghrelin administration on
feeding-regulated peptides in 24 h-fasted JVS mice
To get further insight into the defective anti-famine homeostatic
mechanisms in JVS mice, we examined changes of feeding-regulatory
peptides after ip administration of carnitine and acyl-ghrelin.
Carnitine failed to increase levels of acyl-ghrelin in the blood and
NPY in the hypothalamus and to decrease levels of leptin in the
blood and POMC in the hypothalamus (Fig. 4A–F). Acyl-ghrelin
administration also failed to increase NPY and to decrease leptin and
POMC expression; however, both carnitine and acyl-ghrelin signif-
icantly decreased CRF expression in the hypothalamus of JVS mice
(Fig. 4G).
3.6. Effects of CRF receptor antagonist on food intake in 24 h-fasted
JVS mice
To examine whether increased CRF signaling is involved in the
defective feeding response to fasting, we examined effects of CRF type
2 receptor antagonist on food intake in 24 h-fasted JVS mice (Fig. 5).
There are two types of CRF receptors in the central nervous system
in mammals [27,28], but the type 2 receptor is the chief receptorFig. 4. Effect of intraperitoneal (ip) administration of saline (Na, 150 μl) or carnitine (10 μm
ghrelin (C) in the blood of 24 h-fasting wild type (open column, n= 4) and JVS (closed colum
150 μl), or acyl-ghrelin (Ghr, 10 nmol/150 μl) on leptin in the blood (D) of 24 h-fasted wil
carnitine (Cn, 10 μmol/150 μl), or acyl-ghrelin (Ghr, 10 nmol/150 μl) onmRNA levels of NPY (
(n= 6). ThemRNA levels relative to cyclophilin were calculated with the value of saline-adm
chemicals to the mice. ⁎, pb0.05 vs. wild type mice of the same treatment by Student t tesmediating the anorexic effects of CRF [29,30]. Icv anti-sauvagine-30
signiﬁcantly increased food intake in JVS mice at the dose that did not
affect food intake in wild type animals (Fig. 5).ol/150 μl) on acyl-ghrelin (A), desacyl-ghrelin (B), and ratio of desacyl-ghrelin to acyl-
n, n= 6)mice. Effect of ip administration of saline (Na, 150 μl), carnitine (Cn, 10 μmol/
d type (n= 4) and JVS mice (n= 6). Effect of ip administration of saline (Na, 150 μl),
E), POMC (F), and CRF (G) in the hypothalamus of 24 h-fasted JVSmice by real-time PCR
inistered JVSmice set at 1.0. All samples were collected at 2 h after the administration of
t. #, pb0.05 vs. saline-administered 24 h-fasted JVS mice by Student t test.
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We found that carnitine-deﬁcient JVS mice exhibited defective
feeding response to fasting, a key process known as anti-famine
homeostatic mechanisms (Fig. 6). Administration of acyl-ghrelin and
carnitine normalized the feeding response of 24 h-fasted JVS mice,
with an inhibition of CRF expression in the hypothalamus. Further-
more, CRF type 2 receptor antagonist greatly improved the feeding
response in fasted JVS mice, indicating that the defective acyl-ghrelin
secretion and increased CRF signaling would underlie the feeding
abnormalities of the animals. Ghrelin is a gastric hormone linked to
meal initiation, energy expenditure, and fuel partitioning, and is con-
sidered to facilitate weight gain and impede weight loss as an
indicator of energy insufﬁciency [31,32]. The lowered acyl-ghrelin
with heightened desacyl form suggests the decrease in acylation and/
or the increase in desacylation for processing of preproghrelin. The
acylation process normally requires medium-chain fatty acids [33]
and will be interfered with markedly increased long-chain fatty acids
that are difﬁcult to be metabolized in JVS mice and FAO disorder
patients. The disturbed synthesis and secretion of leptin might also be
produced by similar mechanisms, although leptin may have a limited
role in the defective feeding response since carnitine- and ghrelin-
induced food intakes appear not to involve leptin.
The expression of orexigenic and anorexigenic peptides in the
hypothalamus of fasting JVS mice showed some adaptive response to
fasting, i.e., increased NPY/AGRP and decreased POMC [34,35], which
may be due to defective substrate availability such as glucose and fattyFig. 6. A simpliﬁed model for the defective feeding response to fasting in JVS mice. Fatty
Carnitine is required for transfer of long-chain fatty acids from cytoplasm to mitochondrial m
model and humans results in urinary carnitine wasting and defective fatty acid oxidation, th
as well as decreased ketone and glucose production. Normally, a loss of body fat during fas
release, and/or action of orexigenic acyl-ghrelin and NPY/AGRP, as well as by decreased ac
anti-famine homeostatic mechanism through decreased acyl-ghrelin and disinhibited lep
defective substrate availability (glucose) and beta oxidation (FFA). The net effect is thus com
sensing mechanisms such as hypothalamic adenosine monophosphate-activated protein k
response to fasting through decreased FFA in the blood and lowered CRF expression in theacids. These ﬁndings are consistent with the data by Kuwajima et al.
observed in the infantile period of JVS mice [13] although they did not
discriminate fasted and fed conditions. Recently, Obici et al. indicated
that fatty acids metabolism in the hypothalamus plays an important
role in the control of feeding behavior [36-38]. In these reports,
accumulated fatty acids in the hypothalamus inhibited food intake
through decreased expression of orexigenic NPY and AGRP. However,
the interplay between hypothalamic fatty acid signals and feeding
behavior appears to be complex and how manipulations of central
nervous system fatty acid metabolism are translated into changes in
organism energy balance remains to be determined [39]. Our ﬁndings
of the increased expression of NPY/AGRP in fasted JVS mice suggest
that fatty acid oxidation rather than accumulation is important in the
hypothalamic energy perception. It is likely that the increased
orexigenic activity by NPY/AGRP was canceled by paradoxically
increased anorexigenic activity such as CRF and leptin during fasting
in this animal model.
Icv administration of carnitine failed to improve anorexia of fasted
JVS mice, in marked contrast to the ip administration. Ip administra-
tion of carnitine increased brain carnitine concentrations very slightly
[10,12]. We have reported the effect of ip administration of carnitine
on plasma and tissue carnitine levels [10]. Ip administration (10 μmol)
to 24 h-fasted JVS mice increased the carnitine levels largely in liver
and plasma, but slightly in heart skeletal muscle and brain [10].
Therefore, carnitine should act to suppress the enhanced CRF
signaling through decrease in FFA in the blood and the hypothalamus
[39] leading to initiation of feeding. Actually, FFA in 24 h-fasted JVSacids are predominant substrate for energy production during fasting and starvation.
atrix for their oxidation. Lack of plasma membrane carnitine transporter in this animal
ereby leading to fat accumulation/impaired function in liver, heart, and skeletal muscle,
ting decreases leptin, which leads to positive energy balance by increased production,
tivity of anorexigenic POMC and CRF. In JVS mice, the increased fatty acids disrupt this
tin/CRF, which outweighs some adaptive orexigenic NPY/AGRP response induced by
plex and potential changes in newly identiﬁed feeding-regulatory pathways or energy
inase (AMPK) activity [37,42] need to be examined. Carnitine normalized the feeding
hypothalamus.
1093T. Sakoguchi et al. / Biochimica et Biophysica Acta 1792 (2009) 1087–1093mice decreased after ip administration of carnitine as previously
reported [10]. Accumulated fatty acids in the hypothalamus and
peripheral tissues such as liver produce fatty liver, cardiac hypertro-
phy, and reduced locomotor activity, in addition to defective feeding
response to fasting (Fig. 6). Fasting should be avoided as much as
possible in patients with FAO disorders since hypoglycemia may be
fatal in some cases. Carnitine-deﬁcient JVS mice may be a good model
not only for FAD patients, but also for cachectic cancer and other
patients who also show defective feeding response to fasting/
starvation with secondary hypocarnitinemia [40,41].
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